Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer

Lung cancer (LC) is one of the leading causes of cancer occurrence and mortality worldwide. Treatment of patients with advanced and metastatic LC presents a significant challenge, as malignant cells use different mechanisms to resist chemotherapy. Drug resistance (DR) is a complex process that occur...

Descripción completa

Detalles Bibliográficos
Autores principales: Haider, Mohamed, Elsherbeny, Amr, Pittalà, Valeria, Consoli, Valeria, Alghamdi, Maha Ali, Hussain, Zahid, Khoder, Ghalia, Greish, Khaled
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836587/
https://www.ncbi.nlm.nih.gov/pubmed/35163777
http://dx.doi.org/10.3390/ijms23031853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836587/
https://www.ncbi.nlm.nih.gov/pubmed/35163777
http://dx.doi.org/10.3390/ijms23031853

Ejemplares similares